Dara Bracken‐Clarke

674 total citations · 1 hit paper
19 papers, 351 citations indexed

About

Dara Bracken‐Clarke is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Dara Bracken‐Clarke has authored 19 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 5 papers in Immunology. Recurrent topics in Dara Bracken‐Clarke's work include Cancer Immunotherapy and Biomarkers (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Dara Bracken‐Clarke is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (3 papers). Dara Bracken‐Clarke collaborates with scholars based in United States, Ireland and Italy. Dara Bracken‐Clarke's co-authors include Charalampos S. Floudas, Stephen P. Finn, Anne‐Marie Baird, James L. Gulley, Giovanni Maria Iannantuono, Fatima Karzai, Sinéad Cuffe, Kathy Gately, Mario Roselli and Paul Buchanan and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Dara Bracken‐Clarke

16 papers receiving 344 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Matching patients to clinical trials with large language models

2024 78 citations Qiao Jin, Charalampos S. Floudas et al. Nature Communications profile →

Peers

Countries citing papers authored by Dara Bracken‐Clarke

Since Specialization

Citations

This map shows the geographic impact of Dara Bracken‐Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dara Bracken‐Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dara Bracken‐Clarke more than expected).

Fields of papers citing papers by Dara Bracken‐Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dara Bracken‐Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dara Bracken‐Clarke. The network helps show where Dara Bracken‐Clarke may publish in the future.

Co-authorship network of co-authors of Dara Bracken‐Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Dara Bracken‐Clarke. A scholar is included among the top collaborators of Dara Bracken‐Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dara Bracken‐Clarke. Dara Bracken‐Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer 2026 ·The Oncologist ·Dara Bracken‐Clarke, Danielle M. Pastor, Jennifer L. Marté, Renee N. Donahue, James W. Hodge, Lisa M. Cordes, Charalampos S. Floudas, Nicholas Tschernia, Fatima Karzai, (unknown), (unknown), Patrick Soon‐Shiong, (unknown), (unknown), Hoyoung Maeng, Julius Strauss, Jason M. Redman	0
2	Increased Peripheral T Stem Cell–like Memory Features in Patients with Advanced Solid Tumors Treated with Tumor-Targeting IL-12 Immunocytokine Therapy 2025 ·Clinical Cancer Research ·Meghali Goswami, (unknown), Christine M. Minnar, (unknown), (unknown), Dara Bracken‐Clarke, (unknown), (unknown), Jennifer L. Marté, Sofia R. Gameiro, James L. Gulley, Jeffrey Schlom, Renee N. Donahue	1
3	Analysing the Combined Effects of Radiotherapy and Chemokine Receptor 5 Antagonism: Complementary Approaches to Promote T Cell Function and Migration in Oesophageal Adenocarcinoma 2024 ·Biomedicines ·Maria Davern, (unknown), Noel E. Donlon, (unknown), (unknown), (unknown), (unknown), Dara Bracken‐Clarke, Christine Butler, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght, Melissa J. Conroy	2
4	Utility of Large Language Models for Health Care Professionals and Patients in Navigating Hematopoietic Stem Cell Transplantation: Comparison of the Performance of ChatGPT-3.5, ChatGPT-4, and Bard 2024 ·Journal of Medical Internet Research ·Elisabetta Xue, Dara Bracken‐Clarke, Giovanni Maria Iannantuono, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas	10
5	Comparison of Large Language Models in Answering Immuno-Oncology Questions: A Cross-Sectional Study 2024 ·The Oncologist ·Giovanni Maria Iannantuono, Dara Bracken‐Clarke, Fatima Karzai, Hyoyoung Choo‐Wosoba, James L. Gulley, Charalampos S. Floudas	23
6	Phase II study of enasidenib in IDH2-mutated malignant sinonasal and skull base tumors. 2024 ·Journal of Clinical Oncology ·Elisabetta Xue, Dara Bracken‐Clarke, (unknown), Evrim Türkbey, Lisa M. Cordes, Renee N. Donahue, Seth M. Steinberg, (unknown), Nyall R. London, Jeffrey Schlom, James L. Gulley, Charalampos S. Floudas	1
7	Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer. 2024 ·Journal of Clinical Oncology ·Dara Bracken‐Clarke, Clint Allen, Elisabetta Xue, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, (unknown), Jason M. Redman, Danielle M. Pastor, Renee N. Donahue, Jeffrey Schlom, James L. Gulley, Charalampos S. Floudas	0
8	Genomic and immune profiling of rare non-squamous sinonasal tumors. 2024 ·Journal of Clinical Oncology ·Conor Steuer, Daniel Lubin, Tolulope Adeyelu, James E. Bates, Dong M. Shin, Mihir R. Patel, Nicole C. Schmitt, William A. Stokes, Dara Bracken‐Clarke, Farah Abdulla, Charalampos S. Floudas, Matthew J. Oberley, Jennifer M. Johnson, Trisha M. Wise‐Draper, Marshall R. Posner, Nabil F. Saba	1
9	Matching patients to clinical trials with large language models breakdown → 2024 ·Nature Communications ·Qiao Jin, (unknown), Charalampos S. Floudas, Fangyuan Chen, (unknown), Dara Bracken‐Clarke, Elisabetta Xue, Yifan Yang, Jimeng Sun, Zhiyong Lu	78
10	Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study 2024 ·The Oncologist ·(unknown), Yasser Ged, Dara Bracken‐Clarke, (unknown), (unknown), Emmet Jordan, Paula Calvert, Miriam O’Connor, Anne M. Horgan	0
11	Applications of large language models in cancer care: current evidence and future perspectives 2023 ·Frontiers in Oncology ·Giovanni Maria Iannantuono, Dara Bracken‐Clarke, Charalampos S. Floudas, Mario Roselli, James L. Gulley, Fatima Karzai	67
12	Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory neuroblastoma. 2023 ·Journal of Clinical Oncology ·Dara Bracken‐Clarke, Nyall R. London, Marissa Mallek, Lisa M. Cordes, Seth M. Steinberg, (unknown), Julius Strauss, Jason M. Redman, Danielle M. Pastor, Jeffrey Schlom, James L. Gulley, Charalampos S. Floudas	1
13	Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells 2023 ·Journal of Cancer Research and Clinical Oncology ·Maria Davern, Dara Bracken‐Clarke, Noel E. Donlon, (unknown), (unknown), (unknown), (unknown), Melissa J. Conroy, (unknown), Christine Butler, Claire Donohoe, (unknown), Maeve A. Lowery, (unknown), Narayanasamy Ravi, (unknown), (unknown), John V. Reynolds, Joanne Lysaght	4
14	FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy 2022 ·Journal of Cancer Research and Clinical Oncology ·Maria Davern, Noel E. Donlon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Conall Hayes, Dara Bracken‐Clarke, Melissa J. Conroy, (unknown), Dermot O’Toole, (unknown), Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, (unknown), Joanne Lysaght	1
15	Cooperation between chemotherapy and immune checkpoint blockade to enhance anti-tumour T cell immunity in oesophageal adenocarcinoma 2022 ·Translational Oncology ·Maria Davern, Noel E. Donlon, (unknown), (unknown), Conall Hayes, (unknown), Hugo C. Temperley, Christine Butler, (unknown), Jenny Moore, Dara Bracken‐Clarke, Claire Donohoe, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Melissa J. Conroy, Joanne Lysaght	6
16	Vaping and lung cancer – A review of current data and recommendations 2021 ·Lung Cancer ·Dara Bracken‐Clarke, (unknown), Anne‐Marie Baird, Paul Buchanan, Kathy Gately, Sinéad Cuffe, Stephen P. Finn	79
17	The Liquid Biopsy for Lung Cancer: State of the Art, Limitations and Future Developments 2021 ·Cancers ·(unknown), Dara Bracken‐Clarke, (unknown), Anne‐Marie Baird, Stephen P. Finn	60
18	Management of Locally Advanced and Metastatic Esophageal Cancer in the Older Population 2018 ·Current Oncology Reports ·Dara Bracken‐Clarke, (unknown), Anne M. Horgan	12
19	The challenge of treating older patients with pancreaticobiliary malignancies 2018 ·Current Problems in Cancer ·(unknown), Dara Bracken‐Clarke, Anne M. Horgan	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact